Biochimica et Biophysica Acta-Reviews on Cancer

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	299
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	208
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	129
Targeted drug delivery systems in Lymphoma treatment: Advances and clinical perspectives	123
Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy	119
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	117
Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies	110
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	109
Uveal melanoma modeling in mice and zebrafish	99
The bridging role of neutrophils in the progression of inflammation-induced colorectal cancer	93
Nutrition and dietary restrictions in cancer prevention	79
ESR1 activating mutations: From structure to clinical application	76
Advances in epigenetic modifications and cervical cancer research	68
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	68
The role of protein glycosylation in colorectal cancer: From molecular pathways to clinical applications	68
Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities	67
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	66
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	64
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	63
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	61
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	59
Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights	59
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance	57
Detection methods for mitochondrial DNA heteroplasmy and their potential single-cell applications in cancer	55
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	55

In what area of biology has a “new” type of cell death been discovered?	54
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	54
Targeting lipid metabolism in cancer metastasis	53
Yin yang 1: a potential regulator of immune related diseases and cancer immunity	53
Fascin-1 in primary liver cancers, perspectives for targeted therapy	52
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	52
Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	52
Biomarkers in high grade serous ovarian cancer	51
Advances and prospects of mRNA vaccines in cancer immunotherapy	51
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	50
Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope	48
Revisiting CHK1 and WEE1 kinases as therapeutic targets in cancer	48
S100A8 and S100A9 in Cancer	47
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	46
Inhibition of nucleotide excision repair proteins associated with cancer chemotherapy	46
Integrating multi-omics proteomic approaches in deciphering the tumor microenvironment and therapeutic resistance mechanisms in prostate cancer	45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	45
Targeting Cdc20 for cancer therapy	45
The mechanics of anoikis resistance in cancer	43
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	43
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	42
STIM1-mediated calcium signalling in cancer: Its relation to tumour aggressiveness and therapeutic horizons	42
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	42
Multifaceted roles of neutrophils in tumor microenvironment	42
Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression	42
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	41
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	41
Targeting the triad: phenotypic plasticity, tumor microenvironment and bone microenvironment in prostate cancer bone-metastatic events	40
Editorial Board	39
Olfactomedin 4 in cancer development and progression	39
Current advances in comprehensive omics data mining for oncology and cancer research	37
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges	36
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma	35
An overview of BAP1 biological functions and current therapeutics	34
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy	34
The NLRP3 inflammasome and its role in acute myeloid leukemia onset and development	33
Platinum-based systematic therapy in triple-negative breast cancer	33
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions	33
In vitro anticancer properties of anthocyanins: A systematic review	33
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis	33
Targetable axes of tumor-associated macrophages: An MSF framework for precision immunotherapy	32
Combination therapy in cancer: The potential of tetrandrine as a polytherapy for acute myeloid leukemia	32
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer	32
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation	32
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis	32
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment	32
Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low	31
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies	31
ASPORIN: A root of the matter in tumors and their host environment	31
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment	30

Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview	30
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression	30
Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment	29
A role for RIO kinases in the crosshair of cancer research and therapy	29
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations	29
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights	29
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate	28
Dual role of Snail1 as transcriptional repressor and activator	28
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer	28
M6A methylation in tumor immune microenvironment: Multidimensional mechanism and targeted therapy strategies	28
Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog Inhibitor	28
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors	28
Overview of splicing variation in ovarian cancer	28
HOXA1, a breast cancer oncogene	27
Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy	27
Unveiling the TGF-β/Smad signaling in renal carcinoma progression: Prognostic and therapeutic insights	27
The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers	27
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis	27
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment	26
Research progress on the regulatory role of lactate and lactylation in tumor microenvironment	26
New target DDR1: A “double-edged sword” in solid tumors	26
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy	26
Taurine and cancer: Biological properties and multifaceted roles in cancer progression	26
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer	26
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models	25
Metabolic insights into TAMs and the tumor immune microenvironment: Regulatory mechanisms and therapeutic interventions	25
RUNX1 and cancer	25
A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups	25
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review	25
Schwann cells and enteric glial cells: Emerging stars in colorectal cancer	25
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma	25
Dietary sugar intervention: A promising approach for cancer therapy	25
USP7 - a crucial regulator of cancer hallmarks	25
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3	24
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance	24
Stress granules dynamics and promising functions in pancreatic cancer	24
Keratin 1 as a cell-surface receptor in cancer	24
Role of F-box proteins in human upper gastrointestinal tumors	24
Interleukin-1 signaling in solid organ malignancies	24
Sequencing of antibody drug conjugates in breast cancer: Evidence gap and future directions	24
Role of macrophage PKM2 in inflammation and tumor progression and its targeted therapy	24
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas	24
Key methylation modifications in glioma stem cells	23
Epigenetic regulation of cancer-associated fibroblast heterogeneity	23
Targeting the tumor immune microenvironment in chordoma: From mechanistic insights to therapeutic breakthroughs	23
SNARE proteins: Core engines of membrane fusion in cancer	23
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment	23
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers	23
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers	23
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor	23
Advances in the combination of immunoadjuvants and tumor ablation: Mediating immune effects to enhance anti-tumor efficacy	22
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications	22
Radiotherapy modulates autophagy to reshape the tumor immune microenvironment to enhance anti-tumor immunity in esophageal cancer	22
Role of Yin Yang 1 (YY1) on microenvironment, signaling pathways, and epigenetics in lung cancer	22
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy	21
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors	21
Tumoral heterogeneity in neuroblastoma	21
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review	21
Research progress of mitochondria and cytoskeleton crosstalk in tumour development	21
Corrigendum to “Snail1 as a key prognostic biomarker of cancer-associated fibroblasts in breast tumors” [Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, volume 1880 (2025) / 189316]	21
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53	21
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer	21
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response	21
Expression and function of NF-Y subunits in cancer	21
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance	20
Editorial Board	20
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy	20
Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer	20
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer	20
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics	20
Histone deacetylase complexes: Structure, regulation and function	20
Nanoparticulate delivery and targeting of RNA to the brain	20
Tumor microenvironment diversity and plasticity in cancer multidrug resistance	19
Unraveling metastatic timing: insights and challenges from genomic evolution	19
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors	19
Finding the junction between claudins and endometrial carcinoma	19
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives	19
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer	19
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy	19
Anoikis and NETosis in colorectal cancer liver metastasis: the relationship and perspectives	18

The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression	18
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer	18
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm	18
The signaling pathways regulated by KRAB zinc-finger proteins in cancer	18
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases	18
Thymic epithelial tumor medical treatment: A narrative review	18
Osteoblasts in bone metastasis: Key players in the tumor microenvironment and therapeutic targets	18
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways	18
Role of the intratumoral microbiome in tumor progression and therapeutics implications	18
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas	18
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy	18
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes	17
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer	17
Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes	17
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy	17
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance	17
Decoding the role of intratumoral microbiota in gastric cancer	17
GSDM family and glioma	17
Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics	17
Editorial Board	17
The role of exosomes in the tumour microenvironment on macrophage polarisation	17
Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies	17
EV-mediated asymmetrical crosstalk between CAFs and cancer cells in the tumor microenvironment	17
The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors	17
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs	16
Biological function, regulatory mechanism, and clinical application of mannose in cancer	16
A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment	16
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?	16
Editorial Board	16
Cyclin-dependent kinases in DNA damage response	16
Odors and cancer: Current status and future directions	16
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives	16
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology	16
Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics	16
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations	16
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions	16
Interstitial fluid pressure as an emerging biomarker in solid tumors	16
Molecular and immune pathobiology of human angiosarcoma	16
Perioperative immunotherapy for patients with EGFR mutant non-small cell lung cancer: Unexpected potential benefits	16
Corrigendum to “Unveiling the TGF-β/Smad signaling in renal carcinoma progression: Prognostic and therapeutic insights” [Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1880, Issue 4,	16